BofA analysts added Merck (MRK) to the firm’s “US 1 List” and renewed Apple (AAPL) on the list. The list represents BofA’s best investment ideas.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Moderna price target raised to $27 from $24 at BofA
- Bristol Myers and Microsoft Partner to Accelerate AI Lung Cancer Detection
- Amgen downgraded to Market Perform from Outperform at Bernstein
- Merck price target raised to $120 from $100 at TD Cowen
- Modern, Merck announce 5-year data for intismeran autogene with Keytruda